Sfoglia per AUTORE
ADAMO V
Collezione AOU Novara

  

Items : 8

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status. in Journal of hematology & oncology / J Hematol Oncol. 2022 Jan 21;15(1):9. doi: 10.1186/s13045-022-01226-2.

2022
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Russo A; Russano M; Tiseo M; Porzio G; Ficorella C; Addeo A; Friedlaender A; Banna GL; Passiglia F; Spinelli GP; Metro G; Migliorino MR; Zoratto F; Ricciardi S; Mansueto G; Pecci F; Di Marino P; Gori S; De Tursi M; Tuzi A; Della Gravara L; Rastelli F; Macerelli M; Gelibter A; Chiari R; Marchetti P; Antonuzzo L; Mazzoni F; Genova C; et alii...

Definition of High-Risk Early Hormone-Positive HER2-Negative Breast Cancer: A Consensus Review. in Cancers / Cancers (Basel). 2022 Apr 9;14(8):1898. doi: 10.3390/cancers14081898.

2022
AOU Novara

Garutti M; Griguolo G; Botticelli A; Buzzatti G; De Angelis C; Gerratana L; Molinelli C; Adamo V; Bianchini G; Biganzoli L; Curigliano G; De Laurentiis M; Fabi A; Frassoldati A; Gennari A; Marchiò C; Perrone F; Viale G; Zamagni C; Zambelli A; Del Mastro L; De Placido S; Guarneri V; Marchetti P; Puglisi F;

Post-progression outcomes of NSCLC patients with PD-L1 expression ? 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;148:24-35. doi: 10.1016/j.ejca.2021.02.005. Epub 2021 Mar 12.

2021
AOU San Luigi di Orbassano
AO Ordine Mauriziano
AOU Novara

Russo A; Adamo V; Metro G; De Filippis M; Simona C; Natalizio S; Migliorino MR; Ricciardi S; Landi L; Minuti G; Buti S; Nigro O; Cantini L; Russano M; Citarella F; Bracarda S; Filetti M; Zoratto F; Mansueto G; De Tursi M; Gori S; Rocco D; Chiari R; Rastelli F; Gelibter A; Targato G; Signorelli D; De Toma A; Mazzoni F; et alii...

PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort. in Journal of translational medicine / J Transl Med. 2021 Jun 24;19(1):270. doi: 10.1186/s12967-021-02937-9.

2021
AOU Novara

Santini D; Zeppola T; Russano M; Citarella F; Anesi C; Buti S; Tucci M; Russo A; Sergi MC; Adamo V; Stucci LS; Bersanelli M; Mazzaschi G; Spagnolo F; Rastelli F; Giorgi FC; Giusti R; Filetti M; Marchetti P; Botticelli A; Gelibter A; Siringo M; Ferrari M; Marconcini R; Vitale MG; Nicolardi L; Chiari R; Ghidini M; Nigro O; et alii...

Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Jun;150:224-231. doi: 10.1016/j.ejca.2021.03.041. Epub 2021 May 3.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Cannita K; Porzio G; Friedlaender A; Addeo A; Banna GL; Spinelli GP; Russo A; Adamo V; Metro G; Olmetto E; Tabbò F; Migliorino MR; Ricciardi S; Landi L; Minuti G; Tuzi A; Bisonni R; Follador A; Siringo M; Gelibter A; Signorelli D; De Toma A; Garassino MC; Mazzoni F; Russano M; Citarella F; Filetti M; Zoratto F; Mansueto G; et alii...

Prospective, randomised, multicentre, open-label trial, designed to evaluate the best timing of closure of the temporary ileostomy (early versus late) in patients who underwent rectal cancer resection and with indication for adjuvant chemotherapy: the STOMAD (STOMa closure before or after ADjuvant therapy) randomised controlled trial. in BMJ open / BMJ Open. 2021 Feb 19;11(2):e044692. doi: 10.1136/bmjopen-2020-044692.

2021
ASL Torino 5
ASL Torino 4
ASL Asti
ASL Vercelli
ASL Torino 3
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AO Cuneo
ASL Città di Torino
ASL Biella
AOU Città della Salute di Torino
ASL VCO
ASL Cuneo 2
ASL Cuneo 1
ASL Alessandria
AOU Novara

Battafarano F; Trapani R; Gibin E; Mellano A; De Rosa C; Bellora P; Piscioneri D; Cravero F; Serventi A; Giaminardi E; Mazza L; Adamo V; Rimonda R; Brunetti M; Carrera M; Potente F; Panier Suffat L; Pipitone N; Birolo S; Calabrò M; Racca P; Monagheddu C; Saccona F; Ponte E; Mistrangelo M; Santarelli M; Reddavid R; Tomaselli F; Perinotti R; et alii...

Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy. in Journal for immunotherapy of cancer / J Immunother Cancer. 2021 Apr;9(4):e002421. doi: 10.1136/jitc-2021-002421.

2021
AOU San Luigi di Orbassano
ASL Città di Torino
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Russo A; Adamo V; Metro G; Bironzo P; Passiglia F; Migliorino MR; Ricciardi S; Landi L; Minuti G; Bordi P; Tuzi A; Cantini L; Russano M; Citarella F; Santini D; Filetti M; Zoratto F; Mansueto G; Di Marino P; Grassadonia A; Michele T; Inno A; Della Gravara L; Rocco D; Chiari R; Rastelli F; Macerelli M; Marchetti P; Siringo M; et alii...

Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: a retrospective cohort study. in Oncotarget / Oncotarget. 2016 Jun 28;7(26):40085-40094. doi: 10.18632/oncotarget.9485.

2016
AOU Novara

Verzoni E; De Giorgi U; Derosa L; Caffo O; Boccardo F; Facchini G; Porcu L; De Vincenzo F; Zaniboni A; Chiuri VE; Fratino L; Santini D; Adamo V; De Vivo R; Dinota A; Messina C; Ricotta R; Caserta C; Scavelli C; Susi M; Tartarone A; Surace G; Mosca A; Bruno M; Barni S; Grassi P; Procopio G;